Following its FDA approval in the summer, Tonix Pharma's fibromyalgia therapy Tonmya has been launched onto the market in the ...

Radiopharmaceutical innovator AdvanCell has appointed Andrew Kay as Chair of the Board. Kay previously served as CEO of ...

Progress in the treatment of T-cell blood cancers – which are rare – has also been modest. So, much remains to be done to ...

The FDA has started a priority review of BeOne Medicines' BCL2 inhibitor sonrotoclax in relapsed or refractory mantle cell ...

UK researchers have developed a platform that can test whether commercial AI algorithms developed for NHS applications are ...

To find out, pharmaphorum chatted with Jack Kreindler (WellFounded) after his onstage session at Frontiers Health 2025.

YourCoach Health’s Eugene and Marina Borukhovich spoke with pharmaphorum after their Frontiers Health session to get to the ...

Episeras is a Bluetooth-enabled earpiece with a custom-designed, 3D-printed brain activity sensor that monitors for electrical signal patterns in the brain that may indicate a seizure is on the way in ...

Novo Nordisk has jumped the gun on US price reductions for its blockbuster diabetes and weight-loss drug semaglutide, cutting the monthly price to $349, earlier than expected, for people willing to ...

A clinical trial of Vaderis Therapeutics' AKT inhibitor engasertib suggests it could be the first effective treatment for hereditary haemorrhagic telangiectasia (HHT), the second most common inherited ...

In a statement, Denmark-based Lundbeck said it had carried out a "comprehensive assessment" of the bids on the table for ...

Kelonia Therapeutics only started human testing of its in vivo CAR-T therapy for multiple myeloma in August, but already has ...